Individuals with type 2 diabetes (T2D) who develop cancer are more likely to die in the following seven years if they are smokers or physically inactive, according to a new study of more than half a million people being presented ...
Sep 19, 2022
0
29
In a new paper detailing findings from North Carolina State University's GenX Exposure Study, researchers found that elevated levels of per- and polyfluoroalkyl substances (PFAS) were associated with higher total cholesterol ...
Sep 7, 2022
0
17
A novel artificial intelligence (AI) algorithm accurately estimates the risk of heart disease caused by cumulative exposure to cholesterol and blood pressure levels and the benefits of lowering both—thus providing the essential ...
Aug 29, 2022
0
8
Long-term low-density lipoprotein (LDL) cholesterol lowering with evolocumab is safe and well tolerated and leads to further reductions in cardiovascular events compared with shorter treatment, according to late breaking ...
Aug 29, 2022
0
7
To address the current gaps in expert guidance related to the recent development and commercial availability of newer nonstatin agents, the American College of Cardiology published today an expert consensus decision pathway ...
Aug 25, 2022
0
5
Eating one avocado a day for six months was found to have no effect on belly fat, liver fat or waist circumference in people with overweight conditions or obesity, according to a new study. However, it did lead to a slight ...
Jul 5, 2022
0
5
A genetic variant that is present in nearly 30% of Greenlanders is linked to high cholesterol and an increased risk of cardiovascular disease, according to a study published on June 9th in the journal Human Genetics and Genomics ...
Jun 9, 2022
0
198
Reducing glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) can improve life expectancy (LE) among people with type 2 diabetes (T2D), according ...
Apr 19, 2022
0
2
Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental "gene silencing" therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.
Apr 3, 2022
0
5
Among patients with a history of ischemic stroke, more intensive low-density lipoprotein cholesterol (LDL-C)-lowering statin-based therapies are associated with a decreased risk for recurrent stroke but an increased risk ...
Feb 22, 2022
0
43
